Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subacromial injection trial for partial rotator cuff tears
RBR-3rp7qz6Completed
- Sponsor
- Universidade de Taubaté
- Start
- Jun 2025
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in partial-thickness rotator cuff tear (PRCT) comparing Group I - Hyaluronic acid, Group II - Platelet-rich plasma and Group III - Platelet-rich fibrin (3 arms). Primary endpoint: Pain improvement at 6 months. Started Jun 2025; status: completed.
02
Drugs
HyFIVEplatelet-rich plasmaplatelet rich fibrin
03
Conditions
partial-thickness rotator cuff tear (PRCT)
Beyond the preview
Go deeper on RBR-3rp7qz6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3rp7qz6.